If you need more lookups,
subscriptions start at $34 USD/month.
Mark Trone Location
Cambridge, MA, US
Mark Trone Work
Senior Vice President, Head of CMC @ (April 2026 - Present)
Head of Pharmaceutical Sciences and Manufacturing @ (October 2025 - April 2026)
Vice President of Formulation Sciences @ (January 2023 - September 2025)
Senior Director of Formulation Sciences @ (September 2022 - December 2023)
Senior Director of Analytical Sciences @ (March 2021 - August 2022)
Senior Director of Analytical Development @ (July 2020 - February 2021)
Director of Analytical Development @ (September 2017 - June 2020)
Director of Analytical Development @ (January 2014 - January 2017)
Senior Scientist I and Senior Scientist II @ (January 2009 - January 2014)
Investigator @ (January 2004 - January 2009)
Senior Research Chemist and Research Fellow @ Merck & Co. (January 2000 - January 2004)
Postdoctoral Fellow @ GlaxoWellcome (January 1999 - January 2000)
Mark Trone Education
North Carolina State University
PhD (Chemistry)
University of Illinois at Urbana-Champaign
BS (Chemistry)
Mark Trone Skills
Analytical Chemistry
Assay Development
Biotechnology
Chemistry
Chromatography
Drug Discovery
GMP
HPLC
LC-MS
Mass Spectrometry
UV/Vis
Drug Development
GLP
Medicinal Chemistry
Technology Transfer
UV/Vis Spectroscopy
High-Performance Liquid Chromatography (HPLC)
High Performance Liquid Chromatography Hplc
Biochemistry
Investigation
Molecular Biology
Strategic Planning
Teaching
Lc Ms
High Performance Liquid Chromatography
Mark Trone Summary
Mark Trone, based in Cambridge, MA, US, is currently a Senior Vice President, Head of CMC at Sionna Therapeutics. Mark Trone brings experience from previous roles at Blueprint Medicines. Mark Trone holds a PhD in Chemistry @ North Carolina State University. With a robust skill set that includes Analytical Chemistry, Assay Development, Biotechnology, Chemistry, Chromatography and more. Mark Trone has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mark Trone?
Find contact details for 700 million professionals.